Combined infliximab and rituximab in necrotising scleritis

Case Reports in Ophthalmology

Volumn 3, Issue 3, 2012, Pages 286-290

  Morarji, Jiten ^a,b   Joshi, Lavnish ^a,b,c   Tomkins Netzer, Oren ^a,b   Lightman, Sue ^a,c   Taylor, Simon R J ^a,b,d  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Granulomatosis with polyangiitis; Infliximab; Rituximab; Scleritis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; INFLIXIMAB; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RITUXIMAB;

AGED; ANTIBODY TITER; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; LYMPHOCYTE COUNT; MALE; NECROTISING SCLERITIS; OSTEOPOROSIS; PRIORITY JOURNAL; SCLERITIS; SHORT COURSE THERAPY; WEGENER GRANULOMATOSIS;

EID: 84879071723     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000342842     Document Type: Article

References (12)

1. Taylor SRJ, et al: Ocular manifestations of Wegener's granulomatosis. Expert Rev Ophthalmol 2007;2:91-103.
2. Sainz de la Maza M, et al: Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology 2012;119:43-50.
3. Stone JH, et al: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010;363:221-232.
4. Taylor SR, et al: Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis. Arthritis Rheum 2009;60:1540-1547.
5. Joshi L, et al: Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective. Ophthalmology 2011;118:2498-2503.
6. Morgan MD, et al: Addition of infliximab to standard therapy for ANCA-associated vasculitis. Nephron Clin Pract 2011;117:c89-c97.
7. Doctor P, et al: Infliximab for the treatment of refractory scleritis. Br J Ophthalmol 2010;94:579-583.
8. Kontkanen M, Paimela L, Kaarniranta K: Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment. Acta Ophthalmol 2010;88:e96-e97.
9. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group: Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351-361.
10. Galor A, et al: Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 2006;113:2317-2323.
11. Curtis JR, et al: The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents. Ann Rheum Dis 2011;70:1401-1406.
12. Leombruno JP, Einarson TR, Keystone EC: The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Ann Rheum Dis 2009;68:1136-1145.